Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.
The phagocyte NADPH oxidase generates superoxide anion and downstream reactive oxidant intermediates in response to infectious threat, and is a critical mediator of antimicrobial host defense and inflammatory responses. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that are recruited by cancer cells, accumulate locally and systemically in advanced cancer, and can abrogate anti-tumor immunity. Prior studies have implicated the phagocyte NADPH oxidase as being an important component promoting MDSC accumulation and immunosuppression in cancer. We therefore used engineered NADPH oxidase-deficient (p47 (phox-/-)) mice to delineate the role of this enzyme complex in MDSC accumulation and function in a syngeneic mouse model of epithelial ovarian cancer. We found that the presence of NADPH oxidase did not affect tumor progression. The accumulation of MDSCs locally and systemically was similar in tumor-bearing wild-type (WT) and p47 (phox-/-) mice. Although MDSCs from tumor-bearing WT mice had functional NADPH oxidase, the suppressive effect of MDSCs on ex vivo stimulated T cell proliferation was NADPH oxidase-independent. In contrast to other tumor-bearing mouse models, our results show that MDSC accumulation and immunosuppression in syngeneic epithelial ovarian cancer is NADPH oxidase-independent. We speculate that factors inherent to the tumor, tumor microenvironment, or both determine the specific requirement for NADPH oxidase in MDSC accumulation and function.
Department of Gynecology, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Heidi E
HE
Godoy
A Nazmul H
AN
Khan
R Robert
RR
Vethanayagam
Melissa J
MJ
Grimm
Kelly L
KL
Singel
Nonna
N
Kolomeyevskaya
Kevin J
KJ
Sexton
Anupama
A
Parameswaran
Scott I
SI
Abrams
Kunle
K
Odunsi
Brahm H
BH
Segal
D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D016207:Cytokines / Q000096:biosynthesis; D018450:Disease Progression; D005122:Exudates and Transudates / Q000276:immunology; D005260:Female; D006098:Granulocytes / Q000473:pathology; D007109:Immunity / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D022423:Myeloid Cells / Q000276:immunology*; D019255:NADPH Oxidases / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000276:immunology / Q000473:pathology; D010537:Peritoneum / Q000473:pathology; D013154:Spleen / Q000473:pathology; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology; D059016:Tumor Microenvironment / Q000276:immunology*
D016207:Cytokines; D019255:NADPH Oxidases; C060505:neutrophil cytosolic factor 1